{"changes":[{"companyHref":"/c/alumebiosciences-com","date":"2026-09-25","documentUrl":null,"domain":"alumebiosciences.com","fact":"latest round","name":"Alume Biosciences Inc","new":{"amountUsd":3100000,"date":"2025-10-30","lead":null,"type":null},"old":{"amountUsd":3100000,"date":"2025-10-30","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-05-16","slug":"alumebiosciences-com","status":"attributed","url":"https://whoraisedwhat.com/c/alumebiosciences-com"}],"country":"US","description":"Alume develops bevonescein (ALM-488), a fluorescent peptide that illuminates nerves intraoperatively. It targets surgeons doing head-and-neck, prostate, and neuro procedures. Differentiator: real-time nerve visualization to reduce iatrogenic nerve injury.","domain":"alumebiosciences.com","employees":null,"founded":2017,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":32.845853,"lng":-117.25757,"location":"La Jolla, CA","name":"Alume Biosciences Inc","rounds":[{"amountQuarantined":false,"amountUsd":3100000,"currency":"USD","date":"2025-10-30","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-16","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"alumebiosciences-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-16","status":"attributed","url":null},{"fact":"existence","publisher":"alumebiosciences.com","retrievedAt":"2026-05-16","status":"self-reported","url":"https://alumebiosciences.com"},{"fact":"description","publisher":"alumebiosciences.com","retrievedAt":"2026-05-16","status":"self-reported","url":"https://alumebiosciences.com"}],"stage":"series-b+","techStack":["LiteSpeed","YouTube","jQuery Migrate 3.4.1","imagesLoaded 5.0.0","PHP","MySQL","wordpress 6.8.5","bootstrap 3.3.5","jquery 3."],"totalRaisedUsd":3100000,"updatedAt":"2026-05-16"}